2017年6月1日 · Antibodies directed against self-erythrocytes capable of induction of hemolysis at excessive or uncompensated rates result in an entity known as AIHA. These antibodies are …

2021年3月11日 · Warm autoimmune hemolytic anemia (wAIHA) is the most prevalent form of autoimmune hemolytic anemia (AIHA), accounting for 60% to 70% of all cases. It is usually …

2016年12月2日 · Autoimmune hemolytic anemia (AIHA) is a rare and heterogeneous disease that affects 1 to 3/100 000 patients per year. AIHA caused by warm autoantibodies (w-AIHA), ie, …

Autoimmune hemolytic anemia (AIHA) is characterized by hemolysis, i.e. the breakdown of red blood cells (RBCs) which occurs with autoantibodies and/or complement, together with …

2020年5月8日 · Autoimmune haemolytic anaemias (AIHA) are a group of diseases characterised by haemolysis due to autoantibodies directed against red blood cell surface antigens, with or …

2023年1月5日 · Autoimmune haemolytic anaemias (AIHA) are acquired haematological disorders caused by increased peripheral erythrocyte destruction mediated by autoantibodies against …

Conclusions: Rituximab seems to be a safe and effective therapy for AIHA in this meta-analysis of observational studies. The authors suggest that it could be used at an earlier point in therapy, …

2020年5月1日 · wAIHA is characterized by binding of polyclonal immunoglobulin (often IgG) to RBC antigens (Rh proteins or glycophorins A–D). This binding is referred to as “warm” in that it …

Warm AIHA is more common in women (female to male ratio approximately 2:1 in adults). The disease is characterized by symptoms due to the anemia including fatigue, exertional …

AIHA is characterized by hemolytic anemia, which is most often revealed by an unusual weakness and fatigue with tachycardia and exertional dyspnea, and also in some cases by jaundice, dark …